Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06316713
Other study ID # IRB_00166637
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 8, 2024
Est. completion date December 31, 2024

Study information

Verified date March 2024
Source University of Utah
Contact Eric Garland, PhD
Phone 801-581-3826
Email eric.garland@socwk.utah.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be a single-site, two-arm randomized controlled trial conducted among Spanish-speaking chronic pain patients. Chronic pain patients will be randomized by a computer-generated randomization schedule with simple random allocation (1:1) to either One MORE or a wait-list control condition (WLC). One MORE will be delivered individually either in-person or via a HIPAA compliant virtual meeting platform.


Recruitment information / eligibility

Status Recruiting
Enrollment 34
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Spanish-speaking - Age 18+ - Diagnosed with a chronic pain condition - Average pain in the previous week > or = 3 - Willingness to participate in study interventions and assessments. Exclusion Criteria: - Non Spanish-speaking - Score of 10 or greater ('high risk') on the suicidality subsection of the MINI - Psychotic episode within the last 12 months as deemed by the corresponding subsection of the MINI - Presence of clinically unstable illness judged to interfere with treatment or study procedures - Unable or unlikely to complete study procedures (e.g., planned major surgery, anticipated move, travel barrier) - Communication or cognitive impairment that limits participation in treatment or study procedures.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
One MORE (Spanish Adaptation)
One MORE is a 2-hour adaptation of the manualized MORE program and will be divided into two, 1-hour segments. In the first segment, participants will be introduced to mindfulness and guided though a body scan practice, which directs participants to systematically shift attention from one part of the body to the next. Participants will also be guided through a mindful pain management practice in which they will learn to deconstruct pain into sensory, emotional, cognitive, and behavioral components. The second segment will focus on managing the negative thoughts and emotion that can amplify pain with mindful reappraisal, as well as learning to focus on increasing the positive emotions that can attenuate pain with mindful savoring.

Locations

Country Name City State
United States University of Utah Salt Lake City Utah

Sponsors (1)

Lead Sponsor Collaborator
University of Utah

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Pain Catastrophizing Change in pain catastrophizing from baseline through 6-week follow-up will be assessed with the Pain Catastrophizing Scale (4 question version). Scores range from 0 to 20, with higher scores reflecting greater pain catastrophizing. Will be completed at baseline, week 2, and week 6.
Other Well-Being Change in well-being from baseline through 6-week follow-up will be assessed with the World Health Organization Well-Being Scale (5 question version). Scores range from 0 to 25, with higher scores indicating greater well-being. Will be completed at baseline, week 2, and week 6.
Other Depression Change in depression from baseline through 6-week follow-up will be assessed with the Patient Health Questionnaire-2. Scores range from 0 to 6, with higher scores reflecting greater depression. Will be completed at baseline, week 2, and week 6.
Other Anxiety Change in anxiety from baseline through 6-week follow-up will be assessed with the Generalized Anxiety Disorder 2-item. Scores range from 0 to 6, with higher scores reflecting greater anxiety. Will be completed at baseline, week 2, and week 6.
Other Mindful Reappraisal of Pain Sensations Change in Mindful Reappraisal of Pain Sensations from baseline through 6-week follow-up will be assessed with the Mindful Reappraisal of Pain Sensations Scale. Scores range from 0 to 54, with higher scores indicating greater mindful reappraisal of pain sensations. Will be completed at baseline, week 2, and week 6.
Other Trait Self-Transcendence Change in trait self-transcendence from baseline through 6-week follow-up will be assessed with the Nondual Awareness Dimensional Assessment - Trait Version. Scores range from 0 to 52, with higher scores reflecting greater trait self-transcendence. Will be completed at baseline, week 2, and week 6.
Other Decentering Change in decentering will be measured with the state version of the Metacognitive Processes of Decentering scale. Scores range from 0 to 10, with higher scores reflecting greater decentering. Will be completed immediately before and after each of the two, 1-hour sessions of the One MORE intervention.
Other State Self-Transcendence Change in self-transcendent state will be measured with the Nondual Awareness Dimensional Assessment - State Version. Scores range from 0 to 10, with higher scores reflecting greater self-transcendence. Will be completed immediately before and after each of the two, 1-hour sessions of the One MORE intervention.
Other State Anxiety Change in state anxiety will be measured with an individual item ("How anxious are you, right now?") rated on a numeric rating scale. Scores range from 0 to 10, with higher scores reflecting greater acute anxiety. Will be completed immediately before and after each of the two, 1-hour sessions of the One MORE intervention.
Primary Pain Intensity & Interference Change in pain intensity and interference from baseline through 6-week follow-up will be assessed with the Pain, Enjoyment, and General Activity scale. Scores range from 0 to 30, with higher scores reflecting greater pain intensity/interference. Will be completed at baseline, week 2, and week 6.
Secondary Acute Pain Change in acute pain will be measured with two individual items ("How much pain are you in, right now?", and "How unpleasant is your pain, right now?") rated on a numeric rating scale. Scores range from 0 to 10, with higher scores reflecting greater acute pain. Will be completed immediately before and after each of the two, 1-hour sessions of the One MORE intervention.
Secondary Acceptability Acceptability will be measured with two individual items ("How acceptable did you find the strategies for managing your pain?") and ("How likely would you be to recommend this therapy to someone else dealing with chronic pain?") Scores range from 0 to 10, with higher scores indicating greater program acceptability. Will be completed immediately after the second of the two, 1-hour sessions of the One MORE intervention.
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
Completed NCT05036499 - PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain N/A